Deutsche Bank Securities rates UHOS's bonds as Buy, offering an above-market return with a yield to worst of 6.40% to the 8/15/18 call. The bonds are seen as a solid credit story with potential to outperform in a market downturn. UHOS's strategic focus on EVM is expected to drive revenue and EBITDA growth, creating more FCF and equity cushion. Potential refinancing or public equity market options are noted. M&A strategy likely involves smaller acquisitions. Risks include operational challenges and competition.
doj/DataSet10/EFTA01385390.pdf
{"title":"Universal Hospital (UHOS) Bond Rating","document_date":"2018-01-03","document_type":"financial","key_organizations":["Universal Hospital","Deutsche Bank Securities Inc."],"reference_numbers":["DB-SDNY-0086674","SDNY_GM_00232858","EFTA01385390"]}